These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6433567)

  • 81. [Lymphocyte subsets in relation to immunosuppression in Mycoplasma pneumoniae pneumonia].
    Yoshida H; Hamada T; Abe H; Tanikawa K; Tanaka S; Irie A; Yoshikawa H; Yoshimura A; Kawahara T
    Kansenshogaku Zasshi; 1988 Jan; 62(1):63-8. PubMed ID: 3137286
    [No Abstract]   [Full Text] [Related]  

  • 82. Neurological manifestations and Mycoplasma pneumoniae infection.
    Jones DB
    Br Med J; 1979 Nov; 2(6198):1144. PubMed ID: 519337
    [No Abstract]   [Full Text] [Related]  

  • 83. Central Nervous System Vasculitis as a Rare Presentation of
    Ahmed AOE; Babikir MMI; Khojali AEM; Arachchige SNM; Abdirahman AM; Mohamed MFH
    Case Rep Neurol; 2020; 12(3):402-409. PubMed ID: 33362518
    [No Abstract]   [Full Text] [Related]  

  • 84. Pathogenesis and Treatment of Neurologic Diseases Associated With
    D'Alonzo R; Mencaroni E; Di Genova L; Laino D; Principi N; Esposito S
    Front Microbiol; 2018; 9():2751. PubMed ID: 30515139
    [No Abstract]   [Full Text] [Related]  

  • 85. A Central Nervous System Disease of Unknown Cause That Occurred in the Minamata Region: Results of an Epidemiological Study.
    Kitamura S; Miyata C; Tomita M; Date S; Kojima T; Minamoto H; Kurimoto S; Noguchi Y; Nakagawa R
    J Epidemiol; 2020 Jan; 30(1):3-11. PubMed ID: 31685726
    [No Abstract]   [Full Text] [Related]  

  • 86. Generalized pustular rash associated with primary atypical pneumonia.
    Matsubara M; Ueda K; Kishimoto S; Yasuno H; Ikada J; Sakagami S; Morioka Y
    J Dermatol; 1982 Jun; 9(3):197-202. PubMed ID: 6752233
    [No Abstract]   [Full Text] [Related]  

  • 87. Altered manifestations of skin disease at sites affected by neurological deficit.
    Azimi E; Lerner EA; Elmariah SB
    Br J Dermatol; 2015 Apr; 172(4):988-93. PubMed ID: 25132518
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Relation of immune response to development of central nervous system lesions in virus infections of man.
    Webb HE; Smith CE
    Br Med J; 1966 Nov; 2(5523):1179-81. PubMed ID: 5331895
    [No Abstract]   [Full Text] [Related]  

  • 89. Viral Infection of the Central Nervous System: An Uncommon Etiology.
    Weirtz C; Burnett M; Campagna J
    Clin Pediatr (Phila); 2018 Jun; 57(6):751-753. PubMed ID: 29067823
    [No Abstract]   [Full Text] [Related]  

  • 90. Asymptomatic cardiac lesions occurring in a viral disease--report of two cases.
    JACKLER JM
    J Maine Med Assoc; 1960 Feb; 51():58-60. PubMed ID: 14406262
    [No Abstract]   [Full Text] [Related]  

  • 91. CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review.
    Koskiniemi M
    Clin Infect Dis; 1993 Aug; 17 Suppl 1(Suppl 1):S52-7. PubMed ID: 8399938
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Mycoplasma pneumonia with hydropneumothorax: A case report.
    Mubarik A; Jupalli A; Iqbal AM; Mohammed SK; Muddassir S; Abdulmagid E
    Respir Med Case Rep; 2019; 26():299-300. PubMed ID: 30859064
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Grisel's syndrome caused by Mycoplasma pneumoniae infection: a case report and review of the literature.
    Falsaperla R; Piattelli G; Marino S; Marino SD; Fontana A; Pavone P
    Childs Nerv Syst; 2019 Mar; 35(3):523-527. PubMed ID: 30209598
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The association between Mycoplasma pneumoniae infection and speech and language impairment: A nationwide population-based study in Taiwan.
    Tsai CS; Chen VC; Yang YH; Hung TH; Lu ML; Huang KY; Gossop M
    PLoS One; 2017; 12(7):e0180402. PubMed ID: 28672017
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.
    Saraya T; Kurai D; Nakagaki K; Sasaki Y; Niwa S; Tsukagoshi H; Nunokawa H; Ohkuma K; Tsujimoto N; Hirao S; Wada H; Ishii H; Nakata K; Kimura H; Kozawa K; Takizawa H; Goto H
    Front Microbiol; 2014; 5():410. PubMed ID: 25157244
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Expression of Mycoplasma proteins carrying an affinity tag in M. pneumoniae allows rapid purification and circumvents problems related to the aberrant genetic code.
    Schmidl SR; Hames C; Stülke J
    Appl Environ Microbiol; 2007 Dec; 73(23):7799-801. PubMed ID: 17933931
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Probing in vivo promoter activities in Mycoplasma pneumoniae: a system for generation of single-copy reporter constructs.
    Halbedel S; Stülke J
    Appl Environ Microbiol; 2006 Feb; 72(2):1696-9. PubMed ID: 16461731
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Multiple-mutation reaction: a method for simultaneous introduction of multiple mutations into the glpK gene of Mycoplasma pneumoniae.
    Hames C; Halbedel S; Schilling O; Stülke J
    Appl Environ Microbiol; 2005 Jul; 71(7):4097-100. PubMed ID: 16000825
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Empiric treatment of ambulatory community-acquired pneumonia: always include treatment for atypical agents.
    Marrie TJ
    Infect Dis Clin North Am; 2004 Dec; 18(4):829-41. PubMed ID: 15555827
    [TBL] [Abstract][Full Text] [Related]  

  • 100. In vivo activity of enzymatic and regulatory components of the phosphoenolpyruvate:sugar phosphotransferase system in Mycoplasma pneumoniae.
    Halbedel S; Hames C; Stülke J
    J Bacteriol; 2004 Dec; 186(23):7936-43. PubMed ID: 15547265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.